S

Stereotaxis Inc
AMEX:STXS

Watchlist Manager
Stereotaxis Inc
AMEX:STXS
Watchlist
Price: 2.29 USD 1.33% Market Closed
Market Cap: 193.9m USD
Have any thoughts about
Stereotaxis Inc?
Write Note

Stereotaxis Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stereotaxis Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Stereotaxis Inc
AMEX:STXS
Pre-Tax Income
-$21.6m
CAGR 3-Years
-36%
CAGR 5-Years
-40%
CAGR 10-Years
-8%
Becton Dickinson and Co
NYSE:BDX
Pre-Tax Income
$2B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Pre-Tax Income
$2.2B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
36%
Stryker Corp
NYSE:SYK
Pre-Tax Income
$4.2B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
Pre-Tax Income
$6.8B
CAGR 3-Years
-6%
CAGR 5-Years
12%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Pre-Tax Income
$2.4B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
15%
No Stocks Found

Stereotaxis Inc
Glance View

Market Cap
194m USD
Industry
Health Care

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.

STXS Intrinsic Value
1.41 USD
Overvaluation 39%
Intrinsic Value
Price
S

See Also

What is Stereotaxis Inc's Pre-Tax Income?
Pre-Tax Income
-21.6m USD

Based on the financial report for Sep 30, 2024, Stereotaxis Inc's Pre-Tax Income amounts to -21.6m USD.

What is Stereotaxis Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-8%

Over the last year, the Pre-Tax Income growth was -9%. The average annual Pre-Tax Income growth rates for Stereotaxis Inc have been -36% over the past three years , -40% over the past five years , and -8% over the past ten years .

Back to Top